Algorithm for Evaluation of a Child After First Episode of UTI

INTRODUCTION / WHY EVALUATE?

• Up to 30-35% have vesicoureteral reflux (VUR)
• 5-10% develop permanent renal scarring after first febrile UTI
• Renal scarring can progress to hypertension, proteinuria, and chronic kidney disease
• Risk of scarring increases with each pyelonephritic episode: 5-10% → 20% → 40% → 60% after 1st, 2nd, 3rd, 4th, and 5th episodes respectively (Campbell Walsh Urology)

STEP 1: CONFIRM DIAGNOSIS (Before Any Imaging)

A. Urine Collection (Method matters)

B. Diagnostic Criteria for UTI

• Urinalysis findings: Pyuria (>5-10 WBC/HPF), bacteriuria, positive leukocyte esterase, positive nitrite
• Leukocyte esterase: high sensitivity, lower specificity; nitrites: high specificity, lower sensitivity (Campbell Walsh)
• Diagnosis requires BOTH pyuria AND bacteriuria (AAP 2011 guideline, still referenced in current practice)

STEP 2: CLASSIFY THE UTI

• Age <12 months
• White race
• Absence of another fever source
• Fever >39°C
• Fever ≥2 days duration

STEP 3: DEFINE "TYPICAL" vs "ATYPICAL" UTI

Atypical UTI features (any ONE = atypical):

1. Seriously ill child
2. Poor urine flow
3. Abdominal or bladder mass
4. Raised creatinine
5. Failure to respond to sensitive antibiotics within 48 hours
6. Infection with organisms other than E. coli
7. Septicemia

Recurrent UTI:

• Two or more episodes of upper UTI
• One episode of upper UTI + one or more episodes of lower UTI
• Three or more episodes of lower UTI

STEP 4: IMAGING ALGORITHM

APPROACH A: "BOTTOM-UP" APPROACH (Current Standard / AAP / Piyush Gupta)

FIRST FEBRILE UTI
       │
       ▼
RENAL BLADDER ULTRASOUND (RBUS)
  - Non-invasive, no radiation
  - Abnormal in ~15% of infants with first febrile UTI
  - Only ~1-2% have findings requiring immediate intervention
       │
  ┌────┴────┐
NORMAL    ABNORMAL (hydronephrosis, scarring,
  │       obstruction, pyonephrosis, abscess,
  │       severe hydronephrosis suggesting
  │       high-grade VUR)
  │             │
  ▼             ▼
No VCUG    VCUG (Voiding Cystourethrogram)
routinely  - Grade VUR (I-V)
  │        - Rule out posterior urethral valves
  │        - Evaluate bladder anatomy
  │
  ▼
Monitor: BP, height, weight at each visit

1. RBUS shows hydronephrosis, scarring, or other findings suggesting high-grade VUR or obstructive uropathy
2. Atypical UTI features present
3. Recurrent febrile UTI (even if previous US was normal)
4. Infant <2 months (some guidelines - consider RBUS + VCUG in all)
5. Clinical scenario: non-E. coli pathogen, septicemia, failure to respond within 72 hours

APPROACH B: "TOP-DOWN" APPROACH (NICE / European guidelines)

FIRST FEBRILE UTI
       │
       ▼
  DMSA SCAN (Acute phase OR 4-6 wks later)
  - Gold standard for acute pyelonephritis (sens. 92%)
  - Identifies renal cortical involvement
       │
  ┌────┴────┐
NORMAL    ABNORMAL (photopenia = APN or scar)
  │             │
  ▼             ▼
No VCUG    VCUG
needed     - Only high-risk group screened

• Misses 15-30% of dilating VUR (limitation of TDA)
• Reduces unnecessary invasive studies
• NICE recommends DMSA 4-6 months AFTER acute infection to identify permanent scarring (not routinely during acute phase)

COMPARATIVE TABLE OF MAJOR GUIDELINE IMAGING STRATEGIES

STEP 5: VCUG DETAILS (When Performed)

• Perform after completing antibiotic therapy (when urine is sterile), not during acute infection
• Child must be awake and include a voiding phase
• VUR Grading (International Classification):

• VUR Grades I-II: often resolve spontaneously
• VUR Grades III-V: higher risk of renal scarring; consider urology referral

STEP 6: DMSA RENAL SCAN

• Gold standard for detecting acute pyelonephritis and renal scarring
• For acute APN: within 2-4 weeks (but usually does not change acute management)
• For scarring detection: 6 months after acute infection (allows reversible lesions to resolve)
• SPECT-DMSA superior to planar imaging
• Sensitivity: 92% for APN; 70% for late scarring
• Dysplasia from congenital reflux appears identical to post-infective scarring

STEP 7: ADDITIONAL INVESTIGATIONS

STEP 8: TREATMENT (Brief - for Completeness)

• Oral antibiotics preferred even for acute pyelonephritis if child can tolerate orally (Campbell Walsh)
• IV antibiotics: If <3 months, vomiting, septic, or immunocompromised
• Duration: 7-14 days for febrile/upper UTI; 3-5 days for lower UTI
• Empirical choices: third-generation cephalosporins, amoxicillin-clavulanate, TMP-SMX (based on local antibiogram)
• Fluoroquinolones: NOT first-line in children; reserved for resistant pathogens (e.g., Pseudomonas)
• Antibiotic prophylaxis: NOT recommended routinely after first UTI (AAP, NICE)
  • Consider in: high-grade VUR, recurrent UTIs, structural anomalies

STEP 9: MANAGEMENT AFTER EVALUATION

1. Counsel parents about high recurrence risk (10-30% develop at least one recurrent UTI)
   • Highest recurrence in first 3-6 months post-UTI
2. Monitor at every visit: Height, weight, blood pressure
3. Bowel and bladder dysfunction (BBD): Must assess in ALL children with UTI
   • BBD is major factor in recurrence - behavioral therapy (regular voiding, bowel regimen) is mainstay
4. Surgical referral if: high-grade VUR (IV-V), obstructive uropathy, posterior urethral valves
5. Follow-up DMSA at 6 months if acute DMSA was abnormal - to confirm/quantify scarring

SUMMARY ALGORITHM (FLOWCHART)

Child with FIRST EPISODE UTI
           │
     ┌─────┴──────┐
  AFEBRILE     FEBRILE
  (Cystitis)   (Likely Pyelonephritis)
     │               │
  Treat           RBUS (renal-bladder US)
  antibiotics          │
  Consider RBUS    ┌───┴───┐
  (selectively)  NORMAL  ABNORMAL
                   │         │
                Monitor    VCUG
                BP/growth  ± MAG3/DMSA
                           │
                   ┌───────┴───────┐
                 VUR            Obstruction
                (grade I-V)     (PUJO, PUV)
                   │                │
              Grade I-II       Urology consult
              Prophylaxis?     Surgical correction
              Monitor
              Grade III-V
              Urology referral
              Consider surgery
                   │
            DMSA at 6 months
            (assess scarring)

KEY POINTS FOR EXAM

1. Bag urine is unreliable for diagnosis; use catheter or SPA in non-toilet-trained children
2. RBUS is the first-line imaging for all febrile UTIs in children 2-24 months (AAP)
3. VCUG is NOT routine after first febrile UTI - only if RBUS is abnormal or UTI is atypical/recurrent
4. DMSA = gold standard for APN and renal scarring; done 6 months post-infection for scarring
5. Bottom-up approach (RBUS → VCUG if abnormal) is current standard in most guidelines
6. Top-down approach (DMSA first → VCUG if abnormal) reduces invasive studies but misses 15-30% dilating VUR
7. Procalcitonin >0.5 ng/mL is best serum marker for APN (better than CRP/WBC)
8. Renal scarring risk increases with each UTI episode: ~5% after 1st → ~60% after 5th pyelonephritic episode
9. BBD (Bladder Bowel Dysfunction) must always be assessed and treated - it is the major modifiable risk factor
10. Antibiotic prophylaxis is NOT routinely recommended after first UTI in children without high-grade VUR

REFERENCES

• Campbell Walsh Wein Urology (pediatric UTI/imaging sections, blocks 8 & 9), pp. 564-570, 2192-2400
• Comprehensive Clinical Nephrology 7th Ed, pp. 1971-1992 (VCUG, DMSA, VUR grading)
• Schwartz's Principles of Surgery 11th Ed, p. 1804 (Pediatric UTI imaging algorithms)
• Nelson Textbook of Pediatrics (UTI chapter - classification, diagnosis, evaluation; referenced in AAP guidelines)
• Piyush Gupta's Essential Pediatrics (UTI evaluation algorithm; bottom-up approach endorsed; RBUS + selective VCUG)
• AAP Clinical Practice Guideline (2011, reaffirmed 2016) - now retired 2021, new guideline pending
• NICE Guidelines (2007, updated) - top-down approach for <3 years atypical/recurrent
• Hari P, Meena J et al. Evidence-based CPG for UTI and primary VUR. Pediatr Nephrol. 2024 May. [PMID: 37897526]
• Yang S et al. Kidney Ultrasonography After First Febrile UTI in Children: Systematic Review and Meta-analysis. JAMA Pediatr. 2023;177(8):764-773. [PMID: 37252727] - Found clinically important US findings in only 3.1% of children, suggesting selective rather than universal US may be appropriate
• ACR Appropriateness Criteria: UTI-Child (2023 Update). J Am Coll Radiol. 2024. [PMID: 38823954]
• EAU/ESPU Pediatric Guidelines on UTI in Children (2026 update). J Pediatr Urol. 2026. [PMID: 40615247]